96 related articles for article (PubMed ID: 9629625)
1. Cardiac effects of sumatriptan: findings of Holter monitoring and review of the literature.
Wöber C; Wessely P; Frey B; Marterer A; Zeiler K
Wien Klin Wochenschr; 1998 May; 110(9):331-7. PubMed ID: 9629625
[TBL] [Abstract][Full Text] [Related]
2. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M
Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
[TBL] [Abstract][Full Text] [Related]
4. Sumatriptan and naproxen sodium for the acute treatment of migraine.
Smith TR; Sunshine A; Stark SR; Littlefield DE; Spruill SE; Alexander WJ
Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111
[TBL] [Abstract][Full Text] [Related]
5. Long-term tolerability of sumatriptan nasal spray in adolescent patients with migraine.
Natarajan S; Jabbour JT; Webster CJ; Richardson MS
Headache; 2004; 44(10):969-77. PubMed ID: 15546259
[TBL] [Abstract][Full Text] [Related]
6. Sumatriptan for the treatment of undifferentiated primary headaches in the ED.
Miner JR; Smith SW; Moore J; Biros M
Am J Emerg Med; 2007 Jan; 25(1):60-4. PubMed ID: 17157685
[TBL] [Abstract][Full Text] [Related]
7. [The efficacy of subcutaneous sumatriptan for the treatment of migraine attack].
Stepień A
Pol Merkur Lekarski; 1999 Jun; 6(36):326-7. PubMed ID: 10481546
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of sumatriptan injection for the treatment of morning migraine: two multicenter, prospective, randomized, double-blind, controlled studies in adults.
Winner P; Adelman J; Aurora S; Lener ME; Ames M
Clin Ther; 2006 Oct; 28(10):1582-91. PubMed ID: 17157114
[TBL] [Abstract][Full Text] [Related]
9. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study.
Winner P; Rothner AD; Wooten JD; Webster C; Ames M
Headache; 2006 Feb; 46(2):212-22. PubMed ID: 16492230
[TBL] [Abstract][Full Text] [Related]
10. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA
Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous sumatriptan compared with usual acute treatments for migraine: clinical and pharmacoeconomic evaluation.
Laloux P; Vakaet A; Monseu G; Jacquy J; Bourgeois P; van der Linden C
Acta Neurol Belg; 1998 Dec; 98(4):332-41. PubMed ID: 9922821
[TBL] [Abstract][Full Text] [Related]
12. Almotriptan versus sumatriptan in migraine treatment: direct medical costs of managing adverse chest symptoms.
Mannix LK; Adelman JU; Goldfarb SD; Von S; Kozma CM
Am J Manag Care; 2002 Feb; 8(3 Suppl):S94-101. PubMed ID: 11859910
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of sumatriptan 50 mg in patients not responding to standard care, in the treatment of mild to moderate migraine. The Sumatriptan 50 mg Italian Study Group.
Pini LA; Fabbri L; Cavazzuti L
Int J Clin Pharmacol Res; 1999; 19(2):57-64. PubMed ID: 10669900
[TBL] [Abstract][Full Text] [Related]
14. Subcutaneous sumatriptan induces changes in frequency pattern in cluster headache patients.
Rossi P; Lorenzo GD; Formisano R; Buzzi MG
Headache; 2004; 44(7):713-8. PubMed ID: 15209695
[TBL] [Abstract][Full Text] [Related]
15. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
[TBL] [Abstract][Full Text] [Related]
16. [Sumatriptan in treatment of migraine and its efficacy and tolerance in self-assessment by patients].
Prusiński A; Barliński J
Pol Tyg Lek; 1996 Mar; 51(10-13):187-9. PubMed ID: 8927561
[No Abstract] [Full Text] [Related]
17. Treatment of migraine headaches with sumatriptan in pregnancy.
Hilaire ML; Cross LB; Eichner SF
Ann Pharmacother; 2004 Oct; 38(10):1726-30. PubMed ID: 15316107
[TBL] [Abstract][Full Text] [Related]
18. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
Diener HC; Gendolla A; Gebert I; Beneke M
Headache; 2005; 45(7):874-82. PubMed ID: 15985104
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
Diener HC
Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
[TBL] [Abstract][Full Text] [Related]
20. Treatment of cluster headache attacks with less than 6 mg subcutaneous sumatriptan.
Gregor N; Schlesiger C; Akova-Oztürk E; Kraemer C; Husstedt IW; Evers S
Headache; 2005 Sep; 45(8):1069-72. PubMed ID: 16109122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
